Highbridge Capital Management’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-42,154
| Closed | -$108K | – | 623 |
|
|
2022
Q3 | $108K | Sell |
42,154
-118,266
| -74% | -$303K | ﹤0.01% | 468 |
|
|
2022
Q2 | $310K | Sell |
160,420
-42,663
| -21% | -$82.4K | 0.01% | 415 |
|
|
2022
Q1 | $603K | Buy |
+203,083
| New | +$603K | 0.01% | 407 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 723 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 986 |
|
|
2017
Q4 | – | Sell |
-210,550
| Closed | -$5.29M | – | 1243 |
|
|
2017
Q3 | $5.29M | Buy |
+210,550
| New | +$5.29M | 0.08% | 225 |
|
|
2017
Q2 | – | Sell |
-38,953
| Closed | -$749K | – | 1269 |
|
|
2017
Q1 | $749K | Buy |
+38,953
| New | +$749K | 0.01% | 603 |
|
|
2016
Q4 | – | Sell |
-38,503
| Closed | -$501K | – | 1371 |
|
|
2016
Q3 | $501K | Buy |
+38,503
| New | +$501K | 0.01% | 671 |
|